Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ATR 
AptarGroup Inc (ATR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/28/2025: ATR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $161.43
1 Year Target Price $161.43
| 4 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -9.98% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/28/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 8.22B USD | Price to earnings Ratio 20.02 | 1Y Target Price 161.43 |
Price to earnings Ratio 20.02 | 1Y Target Price 161.43 | ||
Volume (30-day avg) 7 | Beta 0.51 | 52 Weeks Range 103.23 - 171.96 | Updated Date 11/30/2025 |
52 Weeks Range 103.23 - 171.96 | Updated Date 11/30/2025 | ||
Dividends yield (FY) 1.45% | Basic EPS (TTM) 6.23 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.45% | Operating Margin (TTM) 15.15% |
Management Effectiveness
Return on Assets (TTM) 6.84% | Return on Equity (TTM) 15.62% |
Valuation
Trailing PE 20.02 | Forward PE 24.75 | Enterprise Value 9170976461 | Price to Sales(TTM) 2.24 |
Enterprise Value 9170976461 | Price to Sales(TTM) 2.24 | ||
Enterprise Value to Revenue 2.5 | Enterprise Value to EBITDA 10.9 | Shares Outstanding 65619154 | Shares Floating 65073859 |
Shares Outstanding 65619154 | Shares Floating 65073859 | ||
Percent Insiders 1.07 | Percent Institutions 95.93 |
Upturn AI SWOT
AptarGroup Inc
Company Overview
History and Background
AptarGroup Inc. was founded in 1992 as Seaquist Closures, a division of Pittway Corporation. It evolved through acquisitions and organic growth to become a leading global supplier of a broad range of dispensing, sealing, and active packaging solutions. Pittway was acquired in 2000 by Honeywell. Aptar was spun off from Pittway/Honeywell in 1992. It has grown through strategic acquisitions and organic growth, expanding its global presence and product portfolio.
Core Business Areas
- Aptar Beauty + Home: Provides dispensing solutions, including pumps, sprayers, closures, and decorative components, for the beauty, personal care, home care, and fragrance markets.
- Aptar Pharma: Offers drug delivery solutions for nasal, pulmonary, ophthalmic, dermal, and injectable applications.
- Aptar Food + Beverage: Develops dispensing closures and active packaging solutions for the food and beverage markets, including closures, valves, and dispensing systems.
Leadership and Structure
Stephan B. Tanda serves as the President and CEO. The company operates with a decentralized structure, organized around its core business segments. A Board of Directors provides strategic oversight.
Top Products and Market Share
Key Offerings
- Cosmetic Pumps and Sprayers: Dispensing solutions for fragrances, lotions, and creams. Aptar is a leader in this market, but exact market share data varies globally and by product type. Competitors include Rieke Packaging Systems, Silgan Dispensing Systems, and Mega Pumps. It is difficult to find the exact numbers.
- Metered Dose Inhaler (MDI) Valves: Key component in MDIs for asthma and COPD treatment. Aptar Pharma is a major player in this market. Market share data is difficult to pinpoint precisely due to varying geographic regions and specific product types. Competitors include Bespak (part of Recipharm) and 3M Drug Delivery Systems.
- Food and Beverage Dispensing Closures: Valves and dispensing systems for condiments, beverages, and other food products. Again, market share fluctuates. Competitors include Berry Global and BERICAP.
Market Dynamics
Industry Overview
The dispensing and packaging industry is driven by factors such as consumer preferences for convenience, sustainability, and enhanced product performance. Growing demand for innovative packaging solutions and stringent regulations in the pharmaceutical and food & beverage sectors influence the industry.
Positioning
AptarGroup is positioned as a leader in providing innovative and sustainable dispensing and packaging solutions. Its competitive advantages include its diverse product portfolio, global presence, strong customer relationships, and focus on innovation.
Total Addressable Market (TAM)
The global dispensing and packaging market is estimated to be in the hundreds of billions of dollars. Aptar is well-positioned to capture a significant portion of this TAM through its various business segments and geographic reach.
Upturn SWOT Analysis
Strengths
- Global presence and diversified product portfolio
- Strong customer relationships with leading brands
- Focus on innovation and sustainable solutions
- Leading position in key markets
Weaknesses
- Exposure to raw material price fluctuations
- Dependence on key customers
- Currency exchange rate risk
- Potential for product recalls
Opportunities
- Expanding into emerging markets
- Developing innovative and sustainable packaging solutions
- Acquiring complementary businesses
- Leveraging digital technologies to enhance customer experience
Threats
- Intense competition from established players
- Changing consumer preferences
- Economic downturns
- Stringent regulations on packaging and drug delivery
Competitors and Market Share
Key Competitors
- PKG
- SLGN
- BERY
Competitive Landscape
AptarGroup has advantages in its diverse product portfolio and global reach. Competitors often specialize in specific market segments or geographic regions. ApatarGroup's innovation and sustainability efforts help to differentiate it from competitors.
Major Acquisitions
Voluntis
- Year: 2021
- Acquisition Price (USD millions): 92
- Strategic Rationale: This acquisition expanded Aptar Pharma's digital health offerings and strengthened its position in connected drug delivery solutions.
Growth Trajectory and Initiatives
Historical Growth: AptarGroup has experienced consistent growth over the past decade, driven by strategic acquisitions, product innovation, and expansion into emerging markets.
Future Projections: Analyst estimates project continued growth for AptarGroup, driven by increasing demand for sustainable packaging solutions and drug delivery systems.
Recent Initiatives: Recent initiatives include the development of recyclable and biodegradable packaging materials, partnerships with leading brands to implement sustainable packaging solutions, and investments in digital technologies to improve operational efficiency.
Summary
AptarGroup is a well-established player in the dispensing and packaging industry with a strong global presence and diverse product portfolio. Its focus on innovation and sustainability positions it well for future growth. While exposed to raw material price fluctuations and competition, AptarGroup benefits from strong customer relationships and increasing demand for sustainable solutions.
Similar Stocks
Sources and Disclaimers
Data Sources:
- AptarGroup Investor Relations
- Company Press Releases
- Market Research Reports
- Analyst Estimates
- Competitor SEC Filings
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is based on estimates and may vary. Investment decisions should be made after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AptarGroup Inc
Exchange NYSE | Headquaters Crystal Lake, IL, United States | ||
IPO Launch date 1993-04-21 | President, CEO & Executive Director Mr. Stephan B. Tanda | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 13500 | Website https://www.aptar.com |
Full time employees 13500 | Website https://www.aptar.com | ||
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.